Prostate Cancer | Specialty

The OncLive Prostate Cancer condition center page is a comprehensive resource for clinical news and expert insights on how to approach treatment for patients with nonmetastatic, castration-resistant, or castration-sensitive prostate cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, ongoing research, and treatment advances with androgen receptor inhibitors, PARP inhibitors, and more in prostate cancer.

Shifting Therapies to Earlier Settings Could Bolster Treatment Options in mHSPC and Oligometastatic Prostate Cancer

March 26th 2024

Neeraj Agarwal, MD, FASCO, discusses unmet needs across the prostate cancer spectrum and ongoing trials investigating agents in earlier settings.

Dr Koo on PSMA PET Imaging in Prostate Cancer

March 26th 2024

Phillip J. Koo, MD, discusses the use of PSMA PET imaging in prostate cancer.

Dr Spratt on Metastasis-Directed Therapy and Hypofractionation in Prostate Cancer

March 26th 2024

Daniel Spratt, MD, discusses the integration of metastasis-directed therapy and hypofractionation in prostate cancer.

Looking Beyond PSA Is Key to Understanding Nuances of Prostate Cancer Treatment

March 25th 2024

Robert Dreicer, MD, discusses the complex landscape of prostate cancer treatment, highlighting key points from his presentation at the 2024 NY GU.

Taplin Tackles Equitable Treatment in Prostate Cancer

March 24th 2024

Mary-Ellen Taplin, MD, discusses ways to mitigate health care disparities in the treatment of patients with prostate cancer.

Dr Spratt on the Use of Radiation in Low– and High-Risk Prostate Cancer

March 22nd 2024

Daniel Spratt, MD, discusses the use of radiation therapy in low- and high-risk prostate cancer.

Dr Koo on Treating Various Stages of Prostate Cancer

March 22nd 2024

Philip J. Koo, MD, discusses the treatment of patients with prostate cancer throughout the different stages of their disease.

Enzalutamide Receives Positive EU CHMP Opinion for High-Risk Biochemically Recurrent nmHSPC

March 22nd 2024

The EMA’s CHMP has recommended the approval of enzalutamide with or without androgen deprivation therapy in biochemically recurrent nmHSPC.

Dr D’Amico on Advancements in High-Risk Prostate Cancer Diagnosis and Management

March 22nd 2024

Anthony V. D'Amico, MD, PhD, on the advancements in high-risk prostate cancer diagnosis and management

Innovation Is the Answer to Making Progress Against Cancer

March 22nd 2024

Shanta Dhar, PhD, FRSC, discusses the significance of being named a fellow of the National Academy of Inventors for her research in prostate cancer.

Dr Taplin on Health Care Inequities in Prostate Cancer Treatment

March 20th 2024

Mary-Ellen Taplin, MD, discusses strategies to mitigate health care inequities in prostate cancer.

Dr Antonarakis on Early Intervention With PARP Inhibitors in mHSPC

March 20th 2024

Emmanuel Antonarakis, MD, discusses the significance of TALPRO-3, EVOPAR, and AMPLITUDE trials on the metastatic prostate cancer treatment paradigm.

Dr Taplin on Addressing Disparities in Prostate Cancer Care Through Community Engagement

March 15th 2024

Mary-Ellen Taplin, MD, discusses efforts to address disparities in access to, and delivery of, prostate cancer care.

Dr Knight on the Investigation of Patients With Brain-Metastatic Prostate Adenocarcinoma

March 15th 2024

James Knight, MD, discusses the potential launch of a case series of patients with brain-metastatic prostate adenocarcinoma.

Dr Sartor on PSMA PET and Radioligand Therapy in Prostate Cancer

March 13th 2024

Oliver Sartor, MD, discusses the use of PSMA PET and radioligand therapy in prostate cancer.

Dr Sartor on Ongoing Prostate Cancer Research

March 13th 2024

Oliver Sartor, MD, discusses ongoing prostate cancer research, highlighting the importance of considering patient quality of life.

Dr Calais on Controversies in the Treatment of Patients With Prostate Cancer

March 13th 2024

Jeremie Calais, MD, PhD, discusses controversies and unresolved questions in the treatment of patients with prostate cancer.

Dr Zhang on Topics of Ongoing Debate Within Prostate Cancer

March 12th 2024

Tian Zhang, MD, MHS, discusses areas of ongoing debate regarding prostate cancer management.

Dr Agarwal on QOL Considerations for Patients With Prostate Cancer

March 11th 2024

Neeraj Agarwal, FASCO, MD, discusses quality of life considerations for patients with prostate cancer.

Community/Academic Research Collaboration Paves the Way for Improved Cancer Care

March 11th 2024

Gautam Jha, MD, and Emmanuel Antonarakis, MD, discuss the ins and outs of clinical trial partnerships between community and academic cancer centers.